• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速产生双价单价链抗体 鸡免疫和酵母展示筛选。

Expeditious Generation of Biparatopic Common Light Chain Antibodies Chicken Immunization and Yeast Display Screening.

机构信息

Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.

Ferring Darmstadt Laboratory, Biologics Technology and Development, Darmstadt, Germany.

出版信息

Front Immunol. 2020 Dec 23;11:606878. doi: 10.3389/fimmu.2020.606878. eCollection 2020.

DOI:10.3389/fimmu.2020.606878
PMID:33424853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7786285/
Abstract

Bispecific (BsAb) and biparatopic (BpAb) antibodies emerged as promising formats for therapeutic biologics exhibiting tailor-made functional properties. Over recent years, chicken-derived antibodies have gained traction for diagnostic and therapeutic applications due to their broad epitope coverage and convenience of library generation. Here we report the first generation of a biparatopic common light chain (cLC) chicken-derived antibody by an epitope binning-based screening approach using yeast surface display. The resulting monospecific antibodies target conformational epitopes on domain II or III of the epidermal growth factor receptor (EGFR) with lower double- or single-digit nanomolar affinities, respectively. Furthermore, the domain III targeting variant was shown to interfere with epidermal growth factor (EGF) binding. Utilizing the Knob-into-Hole technology (KiH), a biparatopic antibody with subnanomolar affinity was generated that facilitates clustering of soluble and cell-bound EGFR and displayed enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) compared to the parental antibodies. This strategy for generating cLC-based biparatopic antibodies from immunized chickens may pave the way for their further development in therapeutic settings.

摘要

双特异性 (BsAb) 和双价 (BpAb) 抗体作为治疗性生物制剂的有前途的形式出现,具有定制的功能特性。近年来,由于具有广泛的表位覆盖范围和方便的文库生成,鸡源性抗体在诊断和治疗应用中引起了关注。在这里,我们报告了第一代基于表位分组的筛选方法通过酵母表面展示产生的双价通用轻链 (cLC) 鸡源性抗体。由此产生的单特异性抗体针对表皮生长因子受体 (EGFR) 的结构域 II 或 III 上的构象表位,亲和力分别为低至双位数或个位数纳摩尔。此外,靶向域 III 的变体被证明可以干扰表皮生长因子 (EGF) 的结合。利用 Knob-into-Hole 技术 (KiH),生成了具有亚纳摩尔亲和力的双价抗体,可促进可溶性和细胞结合的 EGFR 的聚集,并显示出比亲本抗体更高的抗体依赖性细胞介导的细胞毒性 (ADCC)。这种从免疫鸡中生成基于 cLC 的双价抗体的策略可能为它们在治疗环境中的进一步发展铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/40186b365742/fimmu-11-606878-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/33b8ab351ee4/fimmu-11-606878-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/ef000e4d44b7/fimmu-11-606878-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/7ea64550ceb0/fimmu-11-606878-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/5cdbd5e67d5c/fimmu-11-606878-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/366442f0a78f/fimmu-11-606878-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/40186b365742/fimmu-11-606878-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/33b8ab351ee4/fimmu-11-606878-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/ef000e4d44b7/fimmu-11-606878-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/7ea64550ceb0/fimmu-11-606878-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/5cdbd5e67d5c/fimmu-11-606878-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/366442f0a78f/fimmu-11-606878-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f2/7786285/40186b365742/fimmu-11-606878-g006.jpg

相似文献

1
Expeditious Generation of Biparatopic Common Light Chain Antibodies Chicken Immunization and Yeast Display Screening.快速产生双价单价链抗体 鸡免疫和酵母展示筛选。
Front Immunol. 2020 Dec 23;11:606878. doi: 10.3389/fimmu.2020.606878. eCollection 2020.
2
Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture.基于 2+1 共用轻链抗体结构的三特异性检查点抑制剂和自然杀伤细胞衔接子的设计。
Front Immunol. 2021 May 10;12:669496. doi: 10.3389/fimmu.2021.669496. eCollection 2021.
3
Isolation of Common Light Chain Antibodies from Immunized Chickens Using Yeast Biopanning and Fluorescence-Activated Cell Sorting.利用酵母淘选和荧光激活细胞分选从免疫鸡中分离常见轻链抗体。
Biotechnol J. 2021 Mar;16(3):e2000240. doi: 10.1002/biot.202000240. Epub 2020 Oct 8.
4
Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.普通轻链鸡可产生高亲和力且表位覆盖范围广的人源抗体,用于双特异性抗体的工程化。
MAbs. 2021 Jan-Dec;13(1):1862451. doi: 10.1080/19420862.2020.1862451.
5
Rapid Generation of Chicken Immune Libraries for Yeast Surface Display.用于酵母表面展示的鸡免疫文库的快速构建
Methods Mol Biol. 2020;2070:289-302. doi: 10.1007/978-1-4939-9853-1_16.
6
Yeast Surface Display in Combination with Fluorescence-activated Cell Sorting Enables the Rapid Isolation of Antibody Fragments Derived from Immunized Chickens.酵母表面展示与荧光激活细胞分选相结合,可快速分离免疫鸡源抗体片段。
Biotechnol J. 2019 Apr;14(4):e1800466. doi: 10.1002/biot.201800466. Epub 2018 Nov 28.
7
Anti-EGFR biparatopic-SEED antibody has enhanced combination-activity in a single molecule.双价 EGFR SEED 抗体在单个分子中具有增强的组合活性。
Arch Biochem Biophys. 2012 Oct 15;526(2):219-25. doi: 10.1016/j.abb.2012.03.005. Epub 2012 Mar 10.
8
CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.CD38 特异性双价重链抗体对多发性骨髓瘤细胞显示出强大的补体依赖性细胞毒性。
Front Immunol. 2018 Nov 19;9:2553. doi: 10.3389/fimmu.2018.02553. eCollection 2018.
9
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy.双抗独特型纯化新型天然构象双价抗 MET 抗体,提高体外和体内疗效。
Sci Rep. 2016 Aug 22;6:31621. doi: 10.1038/srep31621.
10
Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.双管齐下:牛科超长 CDR-H3 互补决定区使工程化“近乎天然”的通用轻链双特异性抗体用于效应细胞重定向成为可能。
Front Immunol. 2022 Jan 11;12:801368. doi: 10.3389/fimmu.2021.801368. eCollection 2021.

引用本文的文献

1
A Competition-Based Strategy for the Isolation of an Anti-Idiotypic Blocking Module and Fine-Tuning for Conditional Activation of a Therapeutic Antibody.一种基于竞争的策略,用于分离抗独特型阻断模块并对治疗性抗体的条件激活进行微调。
Biotechnol J. 2024 Dec;19(12):e202400432. doi: 10.1002/biot.202400432.
2
Discovery of potent allosteric antibodies inhibiting EGFR.发现强效变构抗体抑制 EGFR。
MAbs. 2024 Jan-Dec;16(1):2406548. doi: 10.1080/19420862.2024.2406548. Epub 2024 Sep 20.
3
Biparatopic anti-PCSK9 antibody enhances the LDL-uptake in HepG2 cells.

本文引用的文献

1
Humanization of Chicken-Derived scFv Using Yeast Surface Display and NGS Data Mining.利用酵母表面展示和 NGS 数据挖掘实现鸡源性 scFv 的人源化。
Biotechnol J. 2021 Mar;16(3):e2000231. doi: 10.1002/biot.202000231. Epub 2020 Nov 9.
2
Isolation of Common Light Chain Antibodies from Immunized Chickens Using Yeast Biopanning and Fluorescence-Activated Cell Sorting.利用酵母淘选和荧光激活细胞分选从免疫鸡中分离常见轻链抗体。
Biotechnol J. 2021 Mar;16(3):e2000240. doi: 10.1002/biot.202000240. Epub 2020 Oct 8.
3
A Generic Procedure for the Isolation of pH- and Magnesium-Responsive Chicken scFvs for Downstream Purification of Human Antibodies.
双靶向抗 PCSK9 抗体增强 HepG2 细胞对 LDL 的摄取。
Sci Rep. 2024 Jul 3;14(1):15331. doi: 10.1038/s41598-024-66290-9.
4
Balancing the Affinity and Tumor Cell Binding of a Two-in-One Antibody Simultaneously Targeting EGFR and PD-L1.平衡同时靶向表皮生长因子受体(EGFR)和程序性死亡受体配体1(PD-L1)的双功能抗体的亲和力和肿瘤细胞结合能力
Antibodies (Basel). 2024 May 2;13(2):36. doi: 10.3390/antib13020036.
5
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.具有内在激动活性的双表位抗体的简便生成用于激活肿瘤坏死因子受体。
Cell Chem Biol. 2024 May 16;31(5):944-954.e5. doi: 10.1016/j.chembiol.2024.03.010. Epub 2024 Apr 22.
6
Biparatopic antibodies: therapeutic applications and prospects.双靶向抗体:治疗应用与前景。
MAbs. 2024 Jan-Dec;16(1):2310890. doi: 10.1080/19420862.2024.2310890. Epub 2024 Mar 4.
7
Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily.简便生成对肿瘤坏死因子超家族中的激活受体具有内在激动作用的双表位抗体。
bioRxiv. 2023 Dec 12:2023.12.11.571146. doi: 10.1101/2023.12.11.571146.
8
Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment.颠覆癌症免疫疗法:释放双特异性抗体的潜力,实现靶向治疗。
Front Immunol. 2023 Dec 1;14:1291836. doi: 10.3389/fimmu.2023.1291836. eCollection 2023.
9
The Evolving Landscape of Antibody-Drug Conjugates: In Depth Analysis of Recent Research Progress.抗体药物偶联物的发展现状:对近期研究进展的深入分析。
Bioconjug Chem. 2023 Nov 15;34(11):1951-2000. doi: 10.1021/acs.bioconjchem.3c00374. Epub 2023 Oct 11.
10
Single domain Camelid antibody fragments for molecular imaging and therapy of cancer.用于癌症分子成像与治疗的单域骆驼科抗体片段
Front Oncol. 2023 Sep 8;13:1257175. doi: 10.3389/fonc.2023.1257175. eCollection 2023.
一种用于分离pH和镁响应型鸡单链抗体片段以用于人抗体下游纯化的通用方法。
Front Bioeng Biotechnol. 2020 Jun 23;8:688. doi: 10.3389/fbioe.2020.00688. eCollection 2020.
4
Generation of biparatopic antibody through two-step targeting of fragment antibodies on antigen using SpyTag and SpyCatcher.通过使用SpyTag和SpyCatcher对片段抗体进行两步抗原靶向来生成双特异性抗体。
Biotechnol Rep (Amst). 2020 Jan 11;25:e00418. doi: 10.1016/j.btre.2020.e00418. eCollection 2020 Mar.
5
Bispecific antibodies in cancer immunotherapy.双特异性抗体在癌症免疫治疗中的应用。
Curr Opin Biotechnol. 2020 Oct;65:9-16. doi: 10.1016/j.copbio.2019.11.020. Epub 2019 Dec 13.
6
Rapid Generation of Chicken Immune Libraries for Yeast Surface Display.用于酵母表面展示的鸡免疫文库的快速构建
Methods Mol Biol. 2020;2070:289-302. doi: 10.1007/978-1-4939-9853-1_16.
7
Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2.用于MEDI4276临床生物分析的多重液相色谱-串联质谱法,MEDI4276是一种通过可裂解连接子连接到抗HER-2双特异性人源化抗体的微管溶素类似物抗体药物偶联物。
Antibodies (Basel). 2019 Jan 11;8(1):11. doi: 10.3390/antib8010011.
8
Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma.双功能 pH 响应型双特异性抗体用于肿瘤靶向和血浆中抗原耗竭。
Front Immunol. 2019 Aug 9;10:1892. doi: 10.3389/fimmu.2019.01892. eCollection 2019.
9
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.双特异性抗体及抗体构建物在肿瘤学中的综述及临床挑战
Pharmacol Ther. 2019 Sep;201:103-119. doi: 10.1016/j.pharmthera.2019.04.006. Epub 2019 Apr 24.
10
Bp-Bs, a Novel T-cell Engaging Bispecific Antibody with Biparatopic Her2 Binding, Has Potent Anti-tumor Activities.Bp-Bs是一种新型的具有双表位Her2结合能力的T细胞衔接双特异性抗体,具有强大的抗肿瘤活性。
Mol Ther Oncolytics. 2019 Apr 2;14:66-73. doi: 10.1016/j.omto.2019.03.009. eCollection 2019 Sep 27.